The dramatic cost shifting to vulnerable populations that is taking place within the Health Insurance Exchanges is troubling. The Oncology Nursing Society (ONS) believes that access to cancer care is the right of all people. While the Affordable Care Act (ACA) expanded access to insurance coverage, unaffordable co-insurance payments continue to threaten access to cancer care.
People living with chronic conditions like epilepsy often rely on medications to maintain their quality of life, and approximately 2/3 of the nearly 3 million Americans with epilepsy have seizure control largely due to pharmaceutical treatments. The Affordable Care Act meant hope to those who were priced out of the market for health insurance. This hope can be diminished by hitting consumers with high costs at the pharmacy counter. High out-of-pocket costs may force individuals to choose between medications and other essential family costs. Faced with cha